Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Indianapolis, IN
SEC filing record 1 source field available
Fiscal year end
31 December
POINT Biopharma Global Inc. has filed 285 SEC EDGAR filings since 14 May 2020

SEC filing history

Showing 101-125 of 285 matching filings.

Per page
25
Current page
5
EFFECT File 333-265981

EFFECT filing

Filing date
11 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-258325

424B3

Filing date
11 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-258325

EFFECT filing

Filing date
07 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
07 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
07 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-258325

POS AM

Filing date
01 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-265981

S-3

Filing date
01 Jul 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
06 Jun 2022
Reporting date
02 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
06 Jun 2022
Reporting date
02 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
06 Jun 2022
Reporting date
02 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
06 Jun 2022
Reporting date
02 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
06 Jun 2022
Reporting date
02 Jun 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
26 May 2022
Reporting date
25 May 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-258325

424B3

Filing date
16 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-258325

424B3

Filing date
13 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-258325

424B3

Filing date
12 May 2022
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-39373

DEF 14A

Filing date
28 Apr 2022
Reporting date
28 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
05 Apr 2022
Reporting date
01 Apr 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
31 Mar 2022
Reporting date
29 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
31 Mar 2022
Reporting date
29 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
31 Mar 2022
Reporting date
29 Mar 2022
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .